Antimicrobial susceptibilities and analysis of genes related to penicillin or macrolide resistance in Streptococcus pneumoniae

International Journal of Antimicrobial Agents

Volumn 24, Issue 2, 2004, Pages 125-129

  Hiramatsu, Kazufumi ^a   Ohama, Minoru ^a   Mijajima, Yoshiko ^a   Kishi, Kenji ^a   Mizunoe, Syunji ^a   Tokimatsu, Issei ^a   Nagai, Hiroyuki ^a   Kadota, Jun Ichi ^a   Saikawa, Tetsunori ^a   Nasu, Masaru ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Genes related to resistance; Macrolides; Penicillins; Streptococcus pneumoniae; Susceptibility

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM DERIVATIVE; CEFACLOR; CEFCAPENE; CEFDITOREN; CEFOTIAM; CEFTIZOXIME; ERYTHROMYCIN; FROPENEM; IMIPENEM; LEVOFLOXACIN; MACROLIDE; MINOCYCLINE; PENICILLIN G;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; HUMANS; MACROLIDES; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION; PENICILLIN RESISTANCE; PENICILLINS; PEPTIDYL TRANSFERASES; PNEUMONIA, PNEUMOCOCCAL; SPUTUM; STREPTOCOCCUS PNEUMONIAE;

EID: 3342996805     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.02.024     Document Type: Article

References (22)

1. Austrian R., Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann. Intern. Med. 60:1964;759-776
2. Maugein J., Guillemot D., Dupont M.J., et al. Clinical and microbiologial epidemiology of Streptococcus pneumoniae bacteremia in eight French countries. Clin. Microb. Infect. 9:2003;280-288
3. Tomasz A. Antibiotic resistance in Streptococcus pneumoniae. Clin. Infect. Dis. 24:1997;85-88
4. Appelbaum P.C. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:1992;77-83
5. Ubukata K., Muraki T., Igarashi A., Asahi Y., Konno M. In vitro evaluation of the activity of β-lactams, new quinolones, and other antimicrobial agents against Streptococcus pneumoniae. J. Infect. Chemother. 2:1996;213-221
6. Spika J.S., Facklam R.R., Plikaytis B.D., Oxtoby M.J. Antimicrobial resistance of Streptococcus pneumoniae in the United States 1979-1987. J. Infect. Dis. 163:1991;1273-1278
7. Prevalence of penicillin-resistant Streptococcus pneumoniae: Connecticut, 1992-1993. MMWR Morb Mortal Wkly Rep 1994;43:216-7, 223.
8. Drug-resistant Streptococcus pneumoniae - Kentucky and Tennessee, 1993. MMWR Morb Mortal Wkly Rep 1994;43:23-6, 31.
9. Gay K., Baughman W., Miller Y., et al. The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. J. Infect. Dis. 182:2000;1417-1424
10. Tait-Kamradt A., Davies T., Appelbaum P.C., et al. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob. Agents Chemother. 44:2000;3395-3401
11. Okamoto H., Tateda K., Ishii Y., et al. High frequency of erythromycin A resistance and distribution of mefE and ermB genes in clinical isolates of Streptococcus pneumoniae in Japan. J. Infect. Chemother. 8:2002;28-32
12. Ubukata K., Muraki T., Igarashi A., Asahi Y., Konno M. Identification of penicillin and other beta-lactam resistance in Streptococcus pneumoniae by polymerase chain reaction. J. Infect. Chemother. 3:1997;190-197
13. Committee for Revision of MIC Determination Method. Revision of minimal inhibitory concentration (MIC) determination method. Chemotherapy 1981;29:76-9.
14. Nagai K., Shibasaki Y., Hasegawa K., et al. Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and β-lactam resistance, and to detect common macrolide resistance determinants. J. Antimicrob. Chemother. 48:2001;915-918
15. Karlowsky J.A., Thornsberry C., Jones M.E., Evangelista A.T., Critchley I.A., Sahm D.F. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST surveillance program (1998-2002). Clin. Infect. Dis. 36:2003;963-970
16. Whitney C.G., Farley M.M., Hadler J., et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N. Engl. J. Med. 343:2000;1917-1924
17. Chen D.K., McGeer A., de Azavedo J.C., Low D.E. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N. Engl. J. Med. 341:1999;233-239
18. Davidson R., Cavalcanti R., Brunton J.L., et al. Resistant to levofloxacin and failure of treatment of pneumococcal pneumonia. N. Engl. J. Med. 346:2002;747-750
19. Dowson C.G., Coffey T.J., Kell C., Whiley R.A. Evolution of penicillin resistance in Streptococcus pneumoniae; the role of Streptococcus mitis in the formation of a low affinity PBP2B in S. pneumoniae. Mol. Microbiol. 9:1993;635-643
20. Coffy T.J., Dowson C.G., Daniels M., et al. Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural populations of Streptococcus pneumoniae. Mol Microbiol. 5:1991;2255-2260
21. Nava J.M., Bella F., Garau J., et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin. Infect. Dis. 19:1994;884-890
22. Quach C., Weiss K., Moore D., Rubin E., McGeer A., Low D.E. Clinical aspects and cost of invasive Streptococcus pneumoniae infections in children: resistant vs. susceptible strains. Int. J. Antimicrob. Agents. 20:2002;113-118